These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6684440)

  • 1. Microhaemorheological properties of binifibrate. Part II: Preliminary open studies in patients with peripheral arteriopathies.
    Dalmau M; Monasterio J; Nogués R; Picó M; Freixes J; Bruseghini L; Diez S; Andreoli R
    Arzneimittelforschung; 1983; 33(6):858-61. PubMed ID: 6684440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microhaemorheological properties of binifibrate. Part I: Experimental studies.
    Bruseghini L; Freixes J; Andreoli R
    Arzneimittelforschung; 1983; 33(6):854-7. PubMed ID: 6684439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multicenter clinical, double blind, and randomized study to assess the effectiveness and safety of binifibrate versus gemfibrozil in type IIa, IIb, and IV hyperlipidemia].
    Corominas Vilardell A; de Oya Otero M; Escobar Jiménez F; Anguera Vila A; Ariño Armengol B
    An Med Interna; 1993 Nov; 10(11):537-41. PubMed ID: 8117868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a modified fibrate (Biniwas Retard) on hemorheological alterations in hyperlipemic patients.
    Labios M; Martínez M; Vayá A; Gabriel F; Guiral V; Aznar J
    Clin Hemorheol Microcirc; 1999; 21(2):79-85. PubMed ID: 10599590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacodynamic study on nicotinic acid and of one of its higher homologs (3-pyridyl acetic acid) in obliterative arteriopathies of the extremities].
    Spanò G; Saponaro A; Giordano G; Verde AM; Cosentino F; Dagianti A
    Boll Soc Ital Cardiol; 1967; 12(2):148-53. PubMed ID: 5606866
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in blood viscosity and erythrocyte deformability in patients with dyslipidemia treated with binifibrate].
    Labiós Gómez M; Romero Simo M; Gabriel Botella F; Martín Valles H; Morera Llorca M; Freixas Ventura J
    An Med Interna; 1990 Oct; 7(10):517-21. PubMed ID: 2104097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the lipid profiles of hyperlipemic patients treated with binifibrate].
    Avellaneda A; Rueda A; Cascio C; Gutiérrez JA
    An Med Interna; 1993 Jun; 10(6):275-9. PubMed ID: 8334204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardilan in the treatment of obliterative diseases of peripheral arteries].
    Ginko T; Adamczyk R; Dyaczyńska A
    Wiad Lek; 1971 Jun; 24(12):1211-5. PubMed ID: 5561279
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of peripheral circulatory disorders with a nicotinic acid derivative].
    Kienholz E
    Med Klin; 1965 Aug; 60(33):1321-4. PubMed ID: 5843335
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of arteriopathies of limbs by xanthinol nicotinate].
    Elbaz C
    Phlebologie; 1969; 22(1):105-11. PubMed ID: 5775643
    [No Abstract]   [Full Text] [Related]  

  • 11. [The influence of nicotinic acid on circulatory disorders of the lower extremities].
    Kirsch J; Kirsch J
    Landarzt; 1964 Dec; 40(35):1527-30. PubMed ID: 5826399
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of ciclonicate in the treatment of obliterative arteriopathies of the lower limbs].
    Licata G; Pinto A; Parrinello G; Salli L; Indovina I
    Clin Ter; 1985 Mar; 112(6):503-13. PubMed ID: 4017475
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug therapy of arterial circulatory disorders with Lioftal].
    Greif S
    Munch Med Wochenschr; 1969 May; 111(18):1055-8. PubMed ID: 5819199
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new anti-inflammatory agent: niflumic acid].
    Warembourg H; Ducloux G
    Lille Med; 1969 Mar; ():Suppl 2:241-7. PubMed ID: 5402240
    [No Abstract]   [Full Text] [Related]  

  • 15. [Trial of nicergoline in arteriopathies of the lower limbs (apropos of 33 cases)].
    Debaert M; Ribet M; Quandalle P
    Lille Med; 1981 Mar; 26(3):140-3. PubMed ID: 7289750
    [No Abstract]   [Full Text] [Related]  

  • 16. [Complamine in obliterating peripheral circulatory disorders].
    Kusztos D; Bereczky M; Fono J
    Med Monatsschr; 1970 Mar; 24(3):127-8. PubMed ID: 5436974
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of complamin on the disturbances of peripheral circulation in the light of rheoangiographic studies and measurement of skin temperature].
    Dryjski J; Wesolowski J
    Pol Tyg Lek; 1966 Dec; 21(50):1928-30. PubMed ID: 5979808
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analgesic therapy of arteriopathies].
    Rossano C; Testasecca D; Giuliano F; De Luca PF
    Minerva Med; 1974 Mar; 65(24):1286-9. PubMed ID: 4133958
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of a xanthine derivative in peripheral arterial blood flow disorders].
    de Weger WP
    Med Monatsschr; 1970 May; 24(5):221-5. PubMed ID: 5512478
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of arterial occlusion diseases with intraarterial injections in the practice].
    Apel G
    Arzneimittelforschung; 1969 Aug; 19(8):1310-2. PubMed ID: 5820299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.